Related references
Note: Only part of the references are listed.Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer
Hiroyuki Araki et al.
MOLECULAR THERAPY-ONCOLYTICS (2022)
Exploration of p53 plus interferon-beta gene transfer for the sensitization of human colorectal cancer cell lines to cell death
Paulo Roberto Del Valle et al.
CANCER BIOLOGY & THERAPY (2021)
Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity
Xiaolei Zhou et al.
CANCER DISCOVERY (2021)
Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth
Rodrigo Esaki Tamura et al.
GENE THERAPY (2020)
Bicistronic transfer of CDKN2A and p53 culminates in collaborative killing of human lung cancer cells in vitro and in vivo
Juliana G. Xande et al.
GENE THERAPY (2020)
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Oncolytic Viruses and the Immune System: The Dynamic Duo
Ana Lemos de Matos et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Response of human melanoma cell lines to interferon-beta gene transfer mediated by a modified adenoviral vector
Taynah I. P. David et al.
SCIENTIFIC REPORTS (2020)
The Antiviral Apparatus: STING and Oncolytic Virus Restriction
Joel Lee et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer
Bryan E. Strauss et al.
CLINICS (2018)
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
Ruan F. V. Medrano et al.
ONCOTARGET (2017)
Interferon alpha antagonizes the anti-hepatoma activity of the oncolytic virus M1 by stimulating anti-viral immunity
Liu Ying et al.
ONCOTARGET (2017)
Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy
Laetitia Fend et al.
CANCER RESEARCH (2017)
Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death
Aline Hunger et al.
CELL DEATH DISCOVERY (2017)
Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy
Rodrigo Esaki Tamura et al.
CANCER BIOLOGY & THERAPY (2016)
Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy
Ruan Felipe Vieira Medrano et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma
Joao Paulo Portela Catani et al.
TRANSLATIONAL ONCOLOGY (2016)
Preclinical safety and activity of recombinant VSV-IFN-β in an immunocompetent model of squamous cell carcinoma of the head and neck
Vittal V. S. Kurisetty et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
Combined p19Arf and interferon-beta gene transfer enhances cell death of B16 melanoma in vitro and in vivo
C. A. Merkel et al.
CANCER GENE THERAPY (2013)
A rapid and efficient method for purification of recombinant adenovirus with arginine-glycine-aspartic acid-modified fibers
Henry H. Peng et al.
ANALYTICAL BIOCHEMISTRY (2006)
TP53 mutations in human skin cancers
G Giglia-Mari et al.
HUMAN MUTATION (2003)
Human and mouse IFN-β gene therapy exhibits different anti-tumor mechanisms in mouse models
XQ Qin et al.
MOLECULAR THERAPY (2001)
A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the Hl loop of their fiber knob
H Mizuguchi et al.
GENE THERAPY (2001)
Share Paper
